Japanese biotech pays Albireo $135M for local liver disease drug rights
October 12, 2021 at 12:00 PM EDT
Japanese biotech Jadeite Medicines is paying Boston-based Albireo Pharma Inc. up to $135 million for Japanese rights to Bylvay, the company's recently approved drug for rare liver diseases.
